bf/NASDAQ:RGLS_icon.jpeg

COM:REGULUSRX

Regulus Therapeutics

  • Stock

USD

Last Close

1.40

22/11 21:00

Market Cap

115.22M

Beta: -

Volume Today

288.02K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
-39.50K
-
-39.50K
0%
-5.01M
12,584.81%
-2.23M
55.40%
5.17M
331.26%
4.49M
13.14%
4.06M
9.57%
3.62M
10.84%
1.66M
54.21%
1.50K
-
average payables
741.50K
-
1.68M
126.57%
2.45M
45.98%
4.28M
74.45%
5.79M
35.36%
3.73M
35.62%
1.52M
59.30%
928K
38.85%
410K
55.82%
230K
43.90%
189.50K
17.61%
average receivables
39.50K
-
176.50K
346.84%
5.15M
2,816.43%
5.84M
13.43%
1.01M
82.62%
199.50K
80.34%
583.50K
192.48%
822K
40.87%
251.50K
69.40%
1.53M
-
book value per share
291.45
-
359.30
23.28%
289.61
19.40%
127.41
56.01%
56.17
55.91%
-6.71
111.95%
11.60
272.70%
7.44
35.83%
6.41
13.81%
2.18
65.98%
1.12
48.78%
capex per share
-2.60
-
-3.30
26.57%
-3.34
1.27%
-2.19
34.24%
-0.51
76.82%
-0.03
95.04%
-0.14
460.23%
-0.00
97.78%
-0.03
831.31%
-0.02
19.23%
-0.03
36.67%
capex to depreciation
-0.61
-
-0.81
32.38%
-0.90
10.59%
-0.42
52.78%
-0.13
70.22%
-0.01
92.30%
-0.26
2,594.70%
-0.02
91.01%
-0.55
2,221.59%
-2.96
441.11%
-2.70
8.74%
capex to operating cash flow
0.03
-
0.03
3.99%
0.03
6.43%
0.02
40.79%
0.01
68.04%
0.00
90.63%
0.01
2,321.36%
0.00
92.87%
0.01
1,085.55%
0.01
35.95%
0.02
61.93%
capex to revenue
-0.04
-
-0.16
270.07%
-0.07
56.38%
-0.81
1,074.47%
-4.43
447.63%
-0.31
93.10%
-0.04
88.31%
-0.00
96.92%
cash per share
655.53
-
434.77
33.68%
498.15
14.58%
311.92
37.38%
95.82
69.28%
15.98
83.32%
19.77
23.68%
8.89
55.04%
7.05
20.72%
2.57
63.58%
1.26
51.03%
days of inventory on hand
days payables outstanding
328.02
-
days sales outstanding
1.47
-
13.04
785.02%
176.20
1,251.12%
506.54
187.48%
1.89K
273.30%
131.81
93.03%
60.96
53.75%
18.35
69.90%
debt to assets
0.05
-
0.27
425.46%
-0.01
103.10%
0.20
2,415.99%
0.26
30.22%
0.59
132.54%
0.35
41.42%
0.12
64.42%
0.10
16.28%
0.13
29.77%
0.10
24.95%
debt to equity
0.07
-
0.35
418.34%
-0.01
102.71%
0.35
3,756.35%
0.56
60.27%
-2.83
602.09%
0.73
125.82%
0.18
75.55%
0.13
27.83%
0.19
46.20%
0.15
22.37%
dividend yield
earnings yield
-0.07
-
-0.08
22.08%
-0.12
55.16%
-0.69
453.81%
-0.92
33.45%
-6.00
553.23%
-1.21
79.84%
-0.32
73.29%
-1.03
218.69%
-1.35
31.52%
-1.24
8.64%
enterprise value
181.64M
-
693.27M
281.68%
332.99M
51.97%
62.52M
81.22%
84.58M
35.28%
10.75M
87.29%
-4.13M
138.39%
20.78M
603.44%
-26.30M
226.53%
2.96M
111.24%
3.54M
19.79%
enterprise value over ebitda
-10.74
-
-20.92
94.79%
-6.20
70.39%
-0.77
87.57%
-1.24
61.09%
-0.23
81.47%
0.25
206.65%
-1.47
698.73%
0.95
164.39%
-0.10
111.08%
-0.11
9.54%
ev to operating cash flow
-6.41
-
-17.55
173.68%
-6.68
61.94%
-1.10
83.54%
-1.44
30.93%
-0.25
82.73%
0.21
183.82%
-1.66
896.01%
1.09
165.74%
-0.12
110.63%
-0.13
14.23%
ev to sales
9.28
-
90.40
873.94%
16.04
82.26%
52.36
226.44%
1.17K
2,143.44%
149.35
87.29%
-0.60
100.40%
2.08
443.75%
free cash flow per share
-90.95
-
-110.83
21.85%
-119.71
8.02%
-131.44
9.79%
-94.26
28.29%
-49.66
47.32%
-11.63
76.59%
-3.59
69.14%
-2.84
20.70%
-1.70
40.37%
-1.44
14.87%
free cash flow yield
-0.10
-
-0.06
43.86%
-0.11
98.69%
-0.49
325.51%
-0.76
55.15%
-5.34
606.53%
-1.31
75.52%
-0.27
79.66%
-0.90
239.87%
-1.24
37.11%
-1.13
8.89%
graham net net
563.26
-
327.92
41.78%
464.31
41.59%
219.75
52.67%
32.14
85.37%
-20.34
163.26%
8.62
142.37%
6.16
28.52%
5.47
11.17%
1.69
69.18%
0.75
55.38%
graham number
617.88
-
1.12K
80.74%
920.83
17.54%
730.11
20.71%
380.74
47.85%
91.87
75.87%
53.01
42.30%
27.03
49.02%
21.64
19.94%
9.54
55.89%
6.31
33.88%
income quality
1.52
-
0.70
54.07%
0.89
28.30%
0.70
22.28%
0.82
17.59%
0.89
8.69%
1.07
20.00%
0.80
25.25%
0.87
8.87%
0.90
3.87%
0.89
1.12%
intangibles to total assets
0.01
-
0.01
26.83%
0.01
14.25%
0.01
31.60%
0.01
1.22%
0.02
79.75%
0.01
64.69%
0.00
47.41%
0.00
63.52%
0.00
9.46%
0.00
19.14%
interest coverage
-494.50
-
-1.15K
132.87%
-1.05K
8.55%
-68.95
93.45%
-25.76
62.65%
-19.96
22.51%
-7.90
60.42%
-7.83
0.89%
-32.53
315.54%
-41.05
26.16%
-51.50
25.48%
interest debt per share
20.04
-
127.47
535.96%
-2.67
102.09%
47.52
1,882.56%
36.02
24.19%
21.70
39.76%
9.71
55.24%
1.85
80.98%
0.93
49.80%
0.46
50.75%
0.20
57.19%
inventory turnover
invested capital
0.07
-
0.35
418.34%
-0.01
102.71%
0.35
3,756.35%
0.56
60.27%
-2.83
602.09%
0.73
125.82%
0.18
75.55%
0.13
27.83%
0.19
46.20%
0.15
22.37%
market cap
284.36M
-
707.20M
148.70%
448.30M
36.61%
118.83M
73.49%
78.24M
34.16%
8.11M
89.63%
15.36M
89.33%
47.22M
207.39%
27.00M
42.83%
20.91M
22.56%
24.27M
16.09%
net current asset value
87.57M
-
125.48M
43.29%
117.25M
6.56%
42.89M
63.42%
24.14M
43.71%
-14.49M
160.00%
18.34M
226.61%
25.15M
37.14%
51.74M
105.71%
30.65M
40.75%
15.61M
49.09%
net debt to ebitda
6.07
-
0.42
93.08%
2.15
410.43%
0.69
67.66%
-0.09
113.41%
-0.06
39.31%
1.16
2,150.80%
1.87
61.30%
1.92
2.59%
0.64
66.82%
0.67
5.59%
net income per share
-58.22
-
-154.27
164.98%
-130.12
15.65%
-185.94
42.90%
-114.70
38.32%
-55.87
51.29%
-10.77
80.72%
-4.36
59.49%
-3.24
25.64%
-1.86
42.80%
-1.58
14.65%
operating cash flow per share
-88.35
-
-107.53
21.72%
-116.38
8.22%
-129.24
11.06%
-93.75
27.46%
-49.63
47.06%
-11.48
76.86%
-3.58
68.79%
-2.82
21.44%
-1.67
40.59%
-1.41
15.60%
payables turnover
1.11
-
receivables turnover
247.71
-
27.99
88.70%
2.07
92.60%
0.72
65.22%
0.19
73.21%
2.77
1,334.62%
5.99
116.22%
19.89
232.22%
research and ddevelopement to revenue
1.53
-
5.35
249.80%
2.72
49.25%
53.86
1,882.75%
738.78
1,271.75%
471.88
36.13%
1.81
99.62%
1.53
15.14%
return on tangible assets
-0.15
-
-0.33
117.36%
-0.40
19.66%
-0.82
106.25%
-0.93
13.66%
-1.78
90.26%
-0.44
74.96%
-0.41
8.41%
-0.41
0.13%
-0.61
49.26%
-0.98
61.07%
revenue per share
61.03
-
20.87
65.80%
48.45
132.14%
2.71
94.40%
0.11
95.77%
0.08
28.09%
3.96
4,693.08%
2.86
27.73%
roe
-0.20
-
-0.43
114.94%
-0.45
4.65%
-1.46
224.82%
-2.04
39.91%
8.32
507.51%
-0.93
111.16%
-0.59
36.87%
-0.51
13.72%
-0.85
68.14%
-1.42
66.64%
roic
-0.18
-
-0.25
41.05%
-0.45
77.36%
-1.08
141.34%
-1.27
18.12%
-4.37
243.92%
-0.49
88.87%
-0.45
7.86%
-0.43
3.62%
-0.68
58.32%
-1.23
79.68%
sales general and administrative to revenue
0.38
-
1.50
296.13%
0.92
38.72%
15.40
1,571.45%
236.26
1,433.90%
178.61
24.40%
1.66
99.07%
0.88
46.82%
shareholders equity per share
291.45
-
359.30
23.28%
289.61
19.40%
127.41
56.01%
56.17
55.91%
-6.71
111.95%
11.60
272.70%
7.44
35.83%
6.41
13.81%
2.18
65.98%
1.12
48.78%
stock based compensation to revenue
0.17
-
0.92
424.88%
0.74
19.34%
10.78
1,356.23%
106.14
884.54%
75.57
28.80%
0.33
99.56%
0.26
21.99%
tangible asset value
92.33M
-
130.86M
41.74%
123.00M
6.01%
55.06M
55.23%
34.44M
37.45%
-6.35M
118.45%
19.75M
410.81%
25.90M
31.15%
54.88M
111.86%
33.23M
39.45%
21.15M
36.34%
tangible book value per share
287.93
-
356.17
23.70%
287.09
19.40%
125.11
56.42%
54.94
56.09%
-7.29
113.27%
11.44
257.00%
7.41
35.28%
6.40
13.53%
2.18
65.99%
1.12
48.76%
working capital
111.70M
-
156.25M
39.89%
122.82M
21.40%
73.74M
39.96%
34.14M
53.71%
-7.35M
121.53%
18.81M
355.87%
25.15M
33.72%
60.01M
138.58%
32.42M
45.97%
16.66M
48.61%

All numbers in USD (except ratios and percentages)